Research on viral diseases and the response to them. Covers Ebola and mpox, diagnostics, post-viral fatigue, and outbreak control strategies.
A Zika virus vaccine candidate has been shown to prevent fetal malformations and detect maternal antibodies in pregnant animals. The vaccine has demonstrated high levels of protection against Zika infection in both mice and marmosets, with over 90% effectiveness observed.
Researchers developed a school simulation model that shows how the virus spreads in different settings and calculates the effectiveness of measures against its spread. The model reveals that elementary and lower secondary schools can keep reproduction rates below 1 with classroom ventilation, wearing masks, and class size reduction.
A new study by Washington State University scientists reveals that viral proteins interact with each other to disable plant defenses, allowing viruses to hijack their hosts. When some of these proteins are disabled, the virus cannot move from cell to cell, highlighting a promising approach to prevent crop losses.
Researchers at UC Riverside have identified a new host protein interaction in chickens that triggers a strong immune response against viral infections. The discovery sheds light on the differences between bird and human immune responses to zoonotic viruses.
Researchers at University of Washington developed a fast, cheap test for COVID-19 that combines speed of antigen tests with accuracy of PCR tests. The Harmony COVID-19 test detects genetic material from SARS-CoV-2 virus with 97% accuracy and provides results in under 20 minutes.
Researchers created a novel molecular diagnostic platform that can detect COVID-19 genes after only 8 cycles of amplification, significantly reducing the time required for diagnosis. The new SERS-PCR platform uses gold nanoparticles to produce high-sensitivity signals, providing an important tool in the fight against the pandemic.
Biologists at the University of Leeds created high-resolution images of the foot-and-mouth disease virus, revealing fibril structures that play a key role in replication. These findings could lead to new antiviral treatments for diseases caused by the virus.
A study published in PNAS reveals that dengue-infected mosquitoes are more attracted to mammals and bite more often, increasing disease transmission chances. The research found that infected mosquitoes have difficulty locating blood vessels for feeding, leading to increased biting attempts and transmission events.
The Seattle Flu Study's efforts to conduct COVID-19 testing were hindered by conflicting and uncoordinated regulatory actions. The study highlights the importance of a sustainable surveillance system to inform public health policy makers.
Researchers used new technology to study Grapevine Pinot gris virus propagation in a specific vineyard in France. The study found that over 75% of tested plants became infected between 2014 and 2015, with only a marginal number of grapevines testing positive during the remaining five years.
Phages weigh all options and make an informed decision whether to exit the dormant state and attack their bacterial host. The study found that some phage families have developed a complex decision-making strategy, receiving information from neighboring bacteria and controlling communication via arbitrium.
A new study published in Developmental Cell reveals the mechanism of membrane curvature that allows cells to form pockets to capture substances. The researchers used high-resolution fluorescence imaging to watch these pockets form within live cells, providing a clearer understanding of how cells 'eat' and consume substances.
Researchers discovered that human lung stem cells can undergo abnormal differentiation in response to injury from diseases like COVID-19 and pulmonary fibrosis. This aberrant process prevents the restoration of normal lung function, but the study also identified a potential therapeutic target for reversing damage.
Austrian researchers developed a detailed epidemiological model to study the spread of coronavirus in nursing homes. The agent-based simulation tool helps balance safety and quality of life, considering vaccination rates and testing accuracy. With a high vaccination rate, major outbreaks are no longer expected.
New research combines antibiotics and phage therapy to cure infections more effectively and reduce antibiotic use. The study found that bacteriostatic antibiotics trigger CRISPR-Cas adaptive immunity in bacteria, increasing the chances of treatment efficacy.
Researchers found that the risk of developing asthma in infants depends on a complex interplay among the infecting virus, airway microbial composition and function, and the infant's immune response. Infants with distinct metatranscriptome profiles had unique risks of developing asthma by age five.
A novel vaccine, TOH-Vac1, replicates inside the body's cells and generates a powerful immune response in mice and monkeys. The vaccine is based on a strain of vaccinia virus used to vaccinate against smallpox and can be programmed to protect against multiple variants.
Researchers are exploring how an engineered adeno-associated virus (AAV) can compensate for missing protein or swap out genetic mutations that cause vision problems. AAV has been found to be beneficial and is being used as a tool to deliver genes that work as they should.
Researchers mapped how HTLV-1 transforms T-cells into cancerous cells, revealing the virus over-activates them and makes them more vulnerable to DNA damage. This study provides new directions for potential treatments to prevent cancer development.
A clinical trial has revealed that COVID-19 patients on ventilators have less surfactant in their lungs due to the virus. The researchers suggest that giving extra surfactant for a longer period could help save lives by supporting breathing and allowing lung cells to repair after the infection passes.
The Wilderness Medical Society has developed clinical practice guidelines for reducing tick-borne illness, emphasizing low-risk interventions in resource-limited settings. Lyme disease accounts for nearly 70% of reported cases, with other TBIs like anaplasmosis and spotted fever rickettsiosis also on the rise.
A new study found that Omicron's immune-evading capabilities are significant, but some vaccinated and previously infected individuals have 'stronger' protection. However, the protection from Omicron may be compromised over time.
A new white paper shares practical strategies to inform stewardship efforts and ensure appropriate use of antibiotics, citing the public health crisis of antibiotic resistance leading to 23,000 preventable deaths each year. Implementation science principles can bridge the evidence-practice gap.
Researchers found 2.4 times the rate of arbovirosis as originally reported, including coinfections, suggesting underestimation of the incidence of the three viruses. The study enriches epidemiological information on these arboviruses, which can help improve estimates of burden and resource allocation.
Researchers have identified pigtailed macaques as a suitable animal model for studying two emerging tick-borne hemorrhagic viruses, Kyasanur Forest disease and Alkhurma hemorrhagic disease. The study found that infected macaques exhibited symptoms similar to those in humans, including loss of appetite, dehydration, and hemorrhaging.
A recent study found that 19.9% of trans feminine individuals and 2.56% of trans masculine individuals were HIV positive, highlighting the need for targeted prevention efforts. The researchers called for increased focus on this population's unique needs.
A recent review article describes a class of viruses known as oncolytic viruses, which have the remarkable ability to target and destroy cancer cells. Researchers are exploring these viruses for cancer therapy, with some showing promising results in stimulating an immune response against cancer.
Researchers at Monash University have discovered how gamma delta T cells recognize the MHC-like molecule MR1, providing key insights into the immune system's ability to detect infections and diseases. The study sheds light on the unique ways these cells interact with MR1, paving the way for new immunotherapies.
Researchers have discovered that ulvan extracted from marine algae can prevent the infection of cells with the Corona virus. The study suggests that this cheap and accessible natural material may help solve the global spread of the pandemic in developing countries without access to vaccines.
Researchers developed an algorithm predicting COVID-19 patient outcomes based on individual data, achieving high accuracy (over 90%) for up to ten days. This innovation enables hospitals to allocate staff and resources efficiently, potentially saving lives during future pandemic waves.
Researchers have developed a new strategy to combat the tick-borne Crimean-Congo hemorrhagic fever (CCHF) virus by reconstructing its structure and identifying neutralizing antibodies. The study, published in Science, offers insights for developing therapeutics and vaccines against the virus.
Researchers from the University of Copenhagen have discovered that naturally acquired immunity to malaria works differently than immunity following vaccination. The immune system uses natural killer cells to fight the parasite, which is more tailored to the disease than other typical infections.
A gene-silencing therapy harnessing nanoparticles called small extracellular vesicles (sEVs) for drug delivery has protected against Zika virus transmission in pregnant mice to the mouse fetuses. The treatment reduced fetal neurological damage, including virus-induced brain shrinkage.
Researchers found that geriatric cotton rats given ibuprofen cleared RSV more quickly than those without the drug. Ibuprofen improved immune response by lowering aging-related inflammation, suggesting a potential role for the drug in providing lasting immunity against RSV.
Dendritic cells, crucial in detecting infectious agents, need boosting when they are scarce in healthy tissue. A new process, dubbed 'emergency' dendritic cell response, rapidly replenishes these cells from bone marrow upon infection.
Scientists have engineered enzymes to manufacture molnupiravir, resulting in a shorter and higher-yielding synthesis. The new method reduces the risk of hospitalization and death from COVID-19 for newly diagnosed patients, showing promise as an antiviral treatment.
Researchers used machine learning and genomics to identify molecular markers of resistance to sugarcane yellow leaf disease in over 97 sugarcane genotypes. The study found that energy cane varieties with higher fiber content are more resistant to the disease, paving the way for commercial launches.
Researchers found that hepatitis C treatment reduces the activity of proteins involved in cirrhosis, potentially indicating an early sign of liver recovery. The study suggests a possible pathway toward healing scarred liver tissue after virus elimination.
Researchers at Texas A&M University have developed a wearable, self-sustaining fever detector that uses thermal energy harvesting to power its electronic device. The device can generate an unprecedented 87 millivolts per degree Celsius, making it large enough to operate typical wearable electronics.
A recent study published in eLife reveals that the shape of the respiratory syncytial virus (RSV) plays a crucial role in determining infection outcomes. Researchers found that RSV viruses change from long, rod-shaped particles to more rounded ones during infection, which affects the activation of complement proteins by the immune system.
Researchers at Osaka University developed a vaccine that offers cross-protection against SARS coronaviruses by targeting the conserved core region of the spike protein receptor-binding domain. This approach has the potential to protect against future outbreaks, including those caused by novel viruses.
A new study from the University of Southampton demonstrates a safe method to clean and reuse facemask respirators using advanced low-temperature plasma technology. This technique can remove 99.99% of coronavirus while maintaining filter performance, reducing plastic waste by approximately 70%.
Scientists have developed a technique to sequence individual malaria parasites' genomes, allowing for the detection of new mutations. These mutations are often targeting a gene family controlling transcription in malaria, suggesting potential avenues for developing more effective treatments and vaccines.
Research at Florida Atlantic University found that green sea turtles in polluted environments have impaired immune systems, leading to increased disease susceptibility. The study suggests a positive feedback loop where pollution compromises immunity, making turtles more prone to Green Turtle Fibropapillomatosis.
Researchers discovered that RSV's NS1 protein alters immune gene expression to evade the immune response. The study provides crucial data for targeting NS1 in drug or vaccine development and may shed light on the link between RSV and asthma.
A Texas A&M study found that over half of American adults resumed risky social and travel activities before vaccines were widely available. The survey also revealed that younger individuals, those with lower socioeconomic status, and fiscally conservative respondents were more likely to engage in such behaviors.
A new study reveals hepatitis B virus (HBV) has been infecting humans for millennia, tracing its evolution from prehistory to the present. The research highlights HBV's dispersal routes and shifts in viral diversity mirroring human migrations and demographic events.
A pre-clinical study by University of Illinois Chicago researchers shows that a drug targeting specific immune pathways can prevent lung damage and death in mice infected with the SARS-CoV-2 virus. The study suggests targeted treatments may be more suitable for COVID-19 patients than broad immune suppressants.
Dr. Gack's research focuses on identifying broad-spectrum antiviral drug targets and has implications for developing effective treatments against COVID-19 and other viral threats. The $5.6 million NIH grant will support her investigation into targeting human enzymes essential for virus replication.
A new study reveals that high levels of polyunsaturated fatty acids in liver cells are associated with resistance to hepatitis C virus infection. Lipid peroxidation occurs on PUFA-enriched membranes where viral replication machinery is anchored, ultimately shutting off its ability to replicate the viral genome.
Researchers have identified a new prophage-mediated defence system in Salmonella Typhimurium ST313 called BstA, which efficiently suppresses phage attacks. This discovery opens up a new avenue of research and could potentially lead to the development of new biotechnologies.
Researchers discovered a cheap and naturally occurring chemical compound that can prevent or reverse the effects of the deformed wing virus in bees. Bees fed with this compound before becoming infected were nine times more likely to survive the virus after five days.
Researchers found that viral, fungal, or bacterial infections impact blood vessel repair in the brain after traumatic brain injury (TBI) and cerebrovascular injury. Infected animals took longer to repair damaged blood vessels, leading to permanent cognitive dysfunction and brain damage.
Researchers at the University of Illinois found that antibodies from people infected with the original COVID-19 strain do not effectively bind to newer variants. This has implications for vaccine efficacy and the design of possible boosters.
A study published in SLEEP reveals an association between early lower respiratory tract infections and the development of obstructive sleep apnea in children. Children who had a history of severe RSV bronchiolitis during early infancy were found to have a higher risk of developing OSA.
A new study by UCLA researchers reveals that respiratory emissions produced during labor and vaginal delivery can increase the risk of respiratory disease transmission. The findings support the recommendation of providing full PPE, including N95 masks, to healthcare workers in labor and delivery units to prevent COVID-19 transmission.
CD8+ T cell priming in the spleen generates long-lived, stem-like memory T cells with enhanced ability to differentiate into T effector cells. Spleen-primed T cells have superior capacity to respond to rechallenge infection and expand into infection-fighting T effector cells.
Researchers successfully simulated the capsid disassembly step of hepatitis B viral infection at an unprecedented atomic level, identifying specific regions of the capsid protein that contribute to breakage. This high-accuracy simulation can help design drugs to interrupt these processes and prevent chronic infection.
Researchers at Texas A&M University designed a new framework to create the most optimal oxygen concentrator, capable of producing high-purity oxygen and adapting to changing patient needs. The LiLSX-based system outperformed other zeolites in simulation tests.
Researchers at the University of Helsinki discovered a potential contributing mechanism to kidney dysfunction in acute hantavirus infection by investigating the body's response to the virus. Elevated levels of free light chains were found to be associated with kidney problems and may play a role in other infectious diseases.